Smartly Fixing Noisy Glucose Sensor Readings
This patent describes how a continuous glucose monitor automatically detects and replaces unreliable data points, like those caused by sensor noise, to provide more accurate blood sugar readings.
Original patent title: “Systems and methods for replacing signal artifacts in a glucose sensor data stream”
This patent describes how a continuous glucose monitor automatically detects and replaces unreliable data points, like those caused by sensor noise, to provide more accurate blood sugar readings. Granted to Dexcom in 2022 with 24 claims and 1 forward citation, and it is expected to expire in 2038.
Coverage
What does this patent actually cover?
This patent describes a method for an analyte sensor, like a continuous glucose monitor, to automatically correct bad data. First, a hardware processor receives raw data from the sensor and then filters it to create a smoother data stream. The system then compares the raw data to the filtered data to find differences, called "residuals." If these residuals are too large, indicating a "signal artifact event" (like noise or interference), the system selectively chooses from multiple "signal estimation algorithms." Based on this selection, it replaces the problematic raw data with estimated values, creating "modified received data." This modified data is then processed to determine a more accurate estimated analyte value, such as a blood glucose level. For example, if a sensor briefly experiences interference from pressure or movement, this system can detect that bad data and fill in the gap with a reliable estimate.
The gap
What does this patent NOT cover?
- Does not cover systems that detect signal artifacts without comparing received raw data to filtered data to obtain a residual.
- Does not cover systems that use only one signal estimation algorithm for data replacement, or apply algorithms non-selectively without first detecting an artifact.
- Does not cover systems that simply flag or discard noisy data without replacing at least a portion of it with an estimated value.
- Does not cover systems where the replacement of data is not based on the selective application of one of a plurality of signal estimation algorithms.
- Does not cover systems that only filter data without specifically detecting and replacing portions of the received data based on an artifact event.
These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.
Key facts
What made this novel
The cleverness lies in the system's ability to first detect specific data problems by comparing raw and filtered signals, and then to *selectively* apply one of *multiple* different data estimation algorithms to replace only the bad portions. This allows for a more nuanced and robust correction than simply applying a single, constant filtering method.
The Patent Drawing

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.
Where you've seen this
Real-world examples
Dexcom G6 Continuous Glucose Monitoring System
Dexcom G7 Continuous Glucose Monitoring System
Most modern continuous glucose monitoring (CGM) devices
Why it matters
The bigger picture
This technology is crucial for continuous glucose monitoring (CGM) devices, which provide real-time blood sugar readings for people with diabetes. By automatically detecting and correcting noisy or unreliable data, the patent helps ensure that users receive accurate and consistent information. This improves patient safety by reducing the risk of incorrect treatment decisions based on faulty readings, and enhances the overall reliability and trustworthiness of CGM systems.
Filed
June 5, 2018
Granted
September 6, 2022
Market context
Who's building on this
Companies in this space
Dexcom Inc., the assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →, is a leading developer and manufacturer of continuous glucose monitoring systems. They continue to innovate in this space, refining algorithms and sensor technology to provide even more accurate and reliable glucose data. Other major players in the CGM market, such as Abbott and Medtronic, also invest heavily in similar data processing and noise reduction technologies to enhance their own device performance.
Market impact
This patent contributes to the overall reliability and accuracy of continuous glucose monitoring (CGM) devices. By enabling the automatic correction of noisy data, it has helped increase user trust and confidence in CGM systems, fostering their wider adoption among people with diabetes. This improved data quality is essential for making informed health decisions, thereby expanding the market for CGM technology and reducing the burden of diabetes management.
Claim 1 — Plain English
What this patent covers
This patent describes a method for an analyte sensor, like a continuous glucose monitor, to automatically correct bad data. First, a hardware processor receives raw data from the sensor and then filters it to create a smoother data stream. The system then compares the raw data to the filtered data to find differences, called "residuals." If these residuals are too large, indicating a "signal artifact event" (like noise or interference), the system selectively chooses from multiple "signal estimation algorithms." Based on this selection, it replaces the problematic raw data with estimated values, creating "modified received data." This modified data is then processed to determine a more accurate estimated analyte value, such as a blood glucose level. For example, if a sensor briefly experiences interference from pressure or movement, this system can detect that bad data and fill in the gap with a reliable estimate.
The clever bit
The cleverness lies in the system's ability to first detect specific data problems by comparing raw and filtered signals, and then to *selectively* apply one of *multiple* different data estimation algorithms to replace only the bad portions. This allows for a more nuanced and robust correction than simply applying a single, constant filtering method.
What it does not cover
- Does not cover systems that detect signal artifacts without comparing received raw data to filtered data to obtain a residual.
- Does not cover systems that use only one signal estimation algorithm for data replacement, or apply algorithms non-selectively without first detecting an artifact.
- Does not cover systems that simply flag or discard noisy data without replacing at least a portion of it with an estimated value.
- Does not cover systems where the replacement of data is not based on the selective application of one of a plurality of signal estimation algorithms.
- Does not cover systems that only filter data without specifically detecting and replacing portions of the received data based on an artifact event.
Patent timeline
Application submitted to the patent office
Application published, typically 18 months after filing
Patent officially issued
Patent enters public domain
PatentBrief Score
Impact Score
Moderate
Citation count
6/40
Early citations
Claim breadth
16/20
Broad claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →
Recency
20/20
Granted within 5 years
Assignee scale
0/20
Independent or smaller assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →
PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.
Heuristic Value Estimate
What this patent might be worth
$107K – $343K
Midpoint $215K · 11.5 yr remaining · industry ×2.2
Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.
Claim text not yet imported for this patent
The original legal language
Original claims
24 claims as filed with the patent office.
Concepts involved
Citations
Patent lineage
Cite this patent
Li, Y., Boock, R., Brister, M. C., Kamath, A. U., Shariati, M. A., Mahalingam, A., & Brauker, J. H. (2022). Smartly Fixing Noisy Glucose Sensor Readings (U.S. Patent No. 11,432,772). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/11432772/systems-and-methods-for-replacing-signal-artifacts-in-a-glucose-sensor-data-stre-11432772
Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.
Embed
Add this patent to your site
Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.
<div data-patentlens-widget data-patent-number="US11432772"></div> <script src="https://patentbrief.org/embed.js" async></script>
Stay in the loop
Get a weekly digest of new patents.
One email per week. No spam. Unsubscribe anytime.
Keep exploring
Related patents you should know
US 4683195 · 1987
How to Make Billions of Copies of a DNA Segment
This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.
Cetus Corp
US 8697359 · 2014
How to Edit Genes in Human Cells Using an Engineered CRISPR System
This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.
Massachusetts Institute of Technology
US 7657849 · 2010
How the iPhone's Slide-to-Unlock Gesture Works
Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.
Apple Inc
US 4733665 · 1988
How Doctors Implant a Permanent Stent Using a Balloon
This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.
Expandable Grafts Partnership
US 4965188 · 1990
How to Make Many Copies of a DNA Piece with Heat
This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.
Cetus Corp
US 4235871 · 1980
How to Encapsulate Active Materials in Lipid Bubbles Efficiently
This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.
Individual
Semantically similar
You might also find these interesting
US 9282925 · 2016 · Dexcom
How Glucose Sensors Check Their Own Reliability for Insulin Pumps
US 20230293056 · Dexcom
How Continuous Glucose Monitors Get Accurate Readings
US 10052055 · 2018 · Dexcom
How an Implanted Sensor Checks Its Own Accuracy Over Time
US 20230263439 · Dexcom
How a Sensor Checks Itself for Accuracy Using Other Body Data
More to explore
More in Biotech & Medicine
US 4683195 · 1987 · Cetus Corp
How to Make Billions of Copies of a DNA Segment
US 8697359 · 2014 · Massachusetts Institute of Technology
How to Edit Genes in Human Cells Using an Engineered CRISPR System
US 4733665 · 1988 · Expandable Grafts Partnership
How Doctors Implant a Permanent Stent Using a Balloon
US 4965188 · 1990 · Cetus Corp
How to Make Many Copies of a DNA Piece with Heat
New to patents?
Common Questions
Frequently Asked Questions
What does Smartly Fixing Noisy Glucose Sensor Readings cover?
This patent describes how a continuous glucose monitor automatically detects and replaces unreliable data points, like those caused by sensor noise, to provide more accurate blood sugar readings.
Who owns patent US 11432772?
Dexcom owns this patent, granted in 2022.
When does this patent expire?
This patent is expected to expire on June 5, 2038, when the invention enters the public domain.
What is patent US 11432772 cited by?
This patent has been cited by 1 later patents that build on its ideas.
What problem does this patent solve?
This technology is crucial for continuous glucose monitoring (CGM) devices, which provide real-time blood sugar readings for people with diabetes. By automatically detecting and correcting noisy or unreliable data, the patent helps ensure that users receive accurate and consistent information. This improves patient safety by reducing the risk of incorrect treatment decisions based on faulty readings, and enhances the overall reliability and trustworthiness of CGM systems.
What does this patent NOT cover?
Does not cover systems that detect signal artifacts without comparing received raw data to filtered data to obtain a residual.
Same assignee
More from Dexcom
Patent monitoring






